(Français à suivre) We are proud to bring this conversation to life. AI is reshaping how we discover therapeutics and build partnerships across Canada’s life sciences ecosystem, and this episode captures that shift through the lens of people actually doing the work. It’s worth the watch! #MerckCanada *** Nous sommes fiers de donner vie à cette conversation. L’IA transforme la façon dont nous découvrons les thérapies et bâtissons des partenariats au sein de l’écosystème des sciences de la vie au Canada, et cet épisode illustre bien ce changement à travers le regard de celles et ceux qui font ce travail au quotidien. À voir absolument! #MerckCanada
How Is AI Changing Life Sciences? 🧬 AI is no longer just a futuristic concept in life sciences, it is actively reshaping how therapeutics are discovered, how biotech startups scale, and how healthcare ecosystems collaborate. In the first episode or our latest expert series – The Future of Life Sciences, presented by Merck Canada – industry leaders discuss the tangible impacts, challenges, and future of AI adoption across Canada's biotech and healthcare landscape. 🎙️ Meet the Experts: David D. Jones, Managing Director at Merck Canada: Leading the conversation on value recognition for innovative medicines and strategic cross-sector partnerships. Martin Enault, Chief Entrepreneur in Residence at Centech Mtl: A veteran entrepreneur driving the next generation of high-potential tech founders and optimizing team productivity through deliberate AI integration. Handol Kim, Co-Founder and CEO at Variational AI: A pioneer applying generative AI to revolutionize small-molecule drug discovery and accelerate preclinical development. 👉 Watch the interview here: https://lnkd.in/eGz7mfe3 #LifeSciences #ArtificialIntelligence #Biotech #HealthcareInnovation #GenerativeAI #CanadaTech #DrugDiscovery